Synedgen
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1420 N Claremont Blvd Ste 105, Claremont...Phone Number
(909) 447-6858Website
www.synedgen.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About Synedgen
Synedgen specializes in first-in-class therapeutics aimed at restoring mucosal barrier function to improve patient outcomes, particularly in gastrointestinal (GI) diseases. Their lead product, MIIST305, is an orally delivered therapeutic designed to repair GI mucosal injury, reduce inflammation, and restore GI function. The company focuses on targeted therapies with scalable GMP production and strong intellectual property protection. Synedgen's regenerative therapeutics have shown efficacy across multiple modalities, catering to clients in the healthcare and pharmaceutical sectors.Explore more
Synedgen Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Synedgen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Synedgen recently announced quarterly report
Check out if Synedgen is spiking on competitors!
Funding: Get notified immidiatlly once Synedgen has new funding data
Synedgen, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Synedgen has recently received funding, and reach out quickly before it becomes old news!
Click to see if Synedgen had a recent Job posting/layoffs
Product Launch: Get notified when Synedgen launches new products
Congratulate Masked Content for being promoted to Masked Content at Synedgen
Recommended Actions
Reach out to Masked Content who joined Synedgen as Masked Content
Find 3 more new buyers
Compare Similar Companies to Synedgen
Compare insights from companies similar to Synedgen, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Synedgen is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Synedgen is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Synedgen.
Synedgen financials insights
Gather financial insights about Synedgen, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Private Equity
$607K
2015
Private Equity
$3.5M
2016
Unspecified
$6M
Debt
$3M
2017
Debt
$3M
2020
Private Equity
$2.6M
Synedgen Tech Stack
A closer look at the technologies used by Synedgen
Most Recent Scoops
Executive Move
Executive Moves, Board of Directors
Promotion
Executive Move
Executive Moves, Promotion
Left Company
Executive Move
Executive Moves, Left Company
New Hire
Executive Move
Executive Moves, New Hire
Funding
Synedgen News & Media
Synedgen Announces Gut Microbes Publication of Preclinical Data Showing MIIST305 Mitigates Gastrointestinal Acute Radiation Syndrome Injury in a Murine Model
CLAREMONT, Calif.--(BUSINESS WIRE)--Synedgen Announces Gut Microbes Publication of Preclinical Data Showing MIIST305 Mitigates Gastrointestinal ARS Injury in a Murine ModelSynedgen Announces Appointment of Dr. Laura Saward as Chief Scientific Officer
CLAREMONT, Calif.--(BUSINESS WIRE)--Synedgen Announces Appointment of Dr. Laura Saward as Chief Scientific OfficerSynedgen Announces $2.2 Million JWMRP Award for MIIST305 For Use as a Prophylactic Radiation Medical Countermeasure
CLAREMONT, Calif.--(BUSINESS WIRE)--Synedgen Announces $2.2 Million JWMRP Award for MIIST305 For Use as a Prophylactic Radiation Medical CountermeasureSynedgen Receives Contract from BARDA to Develop MIIST305 as a Medical Countermeasure for Gastrointestinal Acute Radiation Syndrome
CLAREMONT, Calif.--(BUSINESS WIRE)--Synedgen Receives Contract from BARDA to Develop MIIST305 as a Medical Countermeasure for Gastrointestinal Acute Radiation Syndrome
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Synedgen
Sign Up For FreeTo access detailed company insights
Synedgen specializes in first-in-class therapeutics aimed at restoring mucosal barrier function to improve patient outcomes, particularly in gastrointestinal (GI) diseases. Their lead product, MIIST305, is an orally delivered therapeutic designed to repair GI mucosal injury, reduce inflammation, and restore GI function. The company focuses on targe... Read More
